TissueGene-C

BIOLOGICAL4 trials

Sponsors

Kolon TissueGene, Inc., Kolon Life Science

Conditions

Degenerative ArthritisOsteoarthritis, Knee

Phase 1

Safety Study of TissueGene-C in Degenerative Joint Disease of the Knee

CompletedNCT00599248

Kolon TissueGene, Inc.Osteoarthritis, Knee

Start: 2007-01-31End: 2010-05-31Updated: 2017-07-07

Phase 2

Study of TG-C in Patients With Grade 3 Degenerative Joint Disease of the Knee

CompletedNCT01221441

Kolon TissueGene, Inc.Osteoarthritis, Knee

Start: 2011-05-31End: 2014-10-31Updated: 2016-02-15

Efficacy and Safety Study of TissueGene-C to Degenerative Arthritis

CompletedNCT01671072

Kolon Life ScienceDegenerative Arthritis

Start: 2011-07-31End: 2013-01-31Updated: 2015-01-22

Phase 3

Efficacy and Safety Study of TissueGene-C to Degenerative Arthritis

CompletedNCT02072070

Kolon Life ScienceDegenerative Arthritis

Start: 2013-11-30End: 2015-08-31Updated: 2017-11-17

Related Papers

Structural effects of intra-articular TGF-β1 in moderate to advanced knee osteoarthritis: MRI-based assessment in a randomized controlled trial.

2017-11-1631 citations

Preliminary results of a phase II randomized study to determine the efficacy and safety of genetically engineered allogeneic human chondrocytes expressing TGF-β1 in patients with grade 3 chronic degenerative joint disease of the knee.

2015-07-1664 citations